BI 443651 Multiple Rising Dose in Healthy Volunteers Followed by a Cross-over in CF Subjects
- First Posted Date
- 2016-11-29
- Last Posted Date
- 2019-11-27
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 64
- Registration Number
- NCT02976519
- Locations
- 🇬🇧
The Medicines Evaluation Unit, Manchester, United Kingdom
🇩🇪Lungenärztliche Praxis, München-Pasing, Germany
🇩🇪Charité - Universitätsmedizin Berlin, Berlin, Germany
Bioavailability of Tiotropium + Olodaterol Fixed-dose Combination (5 μg/ 5 μg) in Chinese COPD Patients
- Conditions
- Pulmonary Disease, Chronic Obstructive
- Interventions
- First Posted Date
- 2016-11-21
- Last Posted Date
- 2019-03-29
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 12
- Registration Number
- NCT02969317
- Locations
- 🇨🇳
West China Hospital, Chengdu, China
Bioequivalence of a Fixed Dose Combination Tablet Containing 400 mg Ibuprofen and 60 mg Pseudoephedrine-HCl Compared to Two Film Coated Fixed Dose Combination Tablets RhinAdvil(R)(200 mg Ibuprofen and 30 mg Pseudoephedrine-HCl) Administered in Healthy Subjects
- First Posted Date
- 2016-11-15
- Last Posted Date
- 2018-09-27
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 56
- Registration Number
- NCT02963701
- Locations
- 🇿🇦
Bloemfontein Early Phase Clinical Unit, PAREXEL International (South Africa), Bloemfontein, South Africa
A Trial to Find and Investigate a Safe Dose of a New Substance (BI 754091) for Patients With Solid Tumours
- First Posted Date
- 2016-11-02
- Last Posted Date
- 2024-04-30
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 112
- Registration Number
- NCT02952248
- Locations
- 🇨🇦
The Ottawa Hospital, Ottawa, Ontario, Canada
🇨🇦Juravinski Cancer Centre - Hamilton Health Sciences, Hamilton, Ontario, Canada
🇨🇦Centre Hospitalier de l'Universite de Montreal (CHUM), Montreal, Quebec, Canada
All-Case Surveillance of Prizbind®
- Conditions
- Hemorrhage
- Interventions
- Drug: Prizbind®
- First Posted Date
- 2016-10-27
- Last Posted Date
- 2022-09-09
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 1402
- Registration Number
- NCT02946931
Safety and Efficacy of Alteplase When Administered in Chinese Patients With Acute Ischemic Hemispheric Stroke Where Thrombolysis is Initiated Between 3 and 4.5 Hours After Stroke Onset
- First Posted Date
- 2016-10-12
- Last Posted Date
- 2019-08-05
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 120
- Registration Number
- NCT02930837
- Locations
- 🇨🇳
Dongguan People's Hospital, Dongguan, China
🇨🇳Renmin Hospital of Wuhan University, Wuhan, China
🇨🇳Yanbian University Hospital, Yanji, China
OTIVACTO Spain Non Interventional Study
- Conditions
- Pulmonary Disease, Chronic Obstructive
- First Posted Date
- 2016-10-07
- Last Posted Date
- 2019-09-30
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 257
- Registration Number
- NCT02927795
- Locations
- 🇪🇸
Centre d'Atenció Primària Calella, Calella (Barcelona), Spain
🇪🇸Centro de Salud del Barrio de Peral, Cartagena (Murcia), Spain
🇪🇸Centro de Salud de Torrekua, Eibar (Guipúzcoa), Spain
A Clinical Trial Comparing Efficacy and Safety of Dabigatran Etexilate With Warfarin in Patients With Cerebral Venous and Dural Sinus Thrombosis (RE-SPECT CVT)
- First Posted Date
- 2016-09-23
- Last Posted Date
- 2019-08-15
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 120
- Registration Number
- NCT02913326
- Locations
- 🇮🇳
Caritas Hospital, Kottayam, India
🇮🇳Mazumdar Shaw Medical centre, Bangalore, India
🇮🇳Nizam's Institute of Medical Sciences, Hyderabad, India
Observational Prospective Study to Evaluate AEs, Risk Factors and Drug Utilization of BUSCAPINA COMPOSITUM N in Adults From Metropolitan Lima
- Conditions
- Acute PainDysmenorrhea
- Interventions
- First Posted Date
- 2016-09-21
- Last Posted Date
- 2019-03-27
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 360
- Registration Number
- NCT02910167
Pharmacokinetics and Safety of BI 695501
- Conditions
- Healthy
- Interventions
- Drug: BI695501AutoinjectorDrug: BI695501 Prefilled syringe
- First Posted Date
- 2016-09-14
- Last Posted Date
- 2018-10-11
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 162
- Registration Number
- NCT02899338
- Locations
- 🇧🇪
SGS Life Sciences Services, Antwerpen, Belgium
🇳🇱PRA Health Sciences Onderzoekscentrum Martini, Groningen, Netherlands